498 related articles for article (PubMed ID: 21572014)
1. Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.
Yin M; van der Horst IC; van Melle JP; Qian C; van Gilst WH; Silljé HH; de Boer RA
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H459-68. PubMed ID: 21572014
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure.
Liu Q; Anderson C; Broyde A; Polizzi C; Fernandez R; Baron A; Parkes DG
Cardiovasc Diabetol; 2010 Nov; 9():76. PubMed ID: 21080957
[TBL] [Abstract][Full Text] [Related]
3. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
[TBL] [Abstract][Full Text] [Related]
4. Metformin improves cardiac function in rats via activation of AMP-activated protein kinase.
Wang XF; Zhang JY; Li L; Zhao XY; Tao HL; Zhang L
Clin Exp Pharmacol Physiol; 2011 Feb; 38(2):94-101. PubMed ID: 21143620
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
[TBL] [Abstract][Full Text] [Related]
6. A new model of congestive heart failure in rats.
Chen J; Chemaly ER; Liang LF; LaRocca TJ; Yaniz-Galende E; Hajjar RJ
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H994-1003. PubMed ID: 21685270
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction.
Inthachai T; Lekawanvijit S; Kumfu S; Apaijai N; Pongkan W; Chattipakorn SC; Chattipakorn N
Exp Physiol; 2015 Jun; 100(6):667-79. PubMed ID: 25823534
[TBL] [Abstract][Full Text] [Related]
8. Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.
Karwi QG; Zhang L; Wagg CS; Wang W; Ghandi M; Thai D; Yan H; Ussher JR; Oudit GY; Lopaschuk GD
Cardiovasc Diabetol; 2019 Jan; 18(1):1. PubMed ID: 30626440
[TBL] [Abstract][Full Text] [Related]
9. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure.
Gundewar S; Calvert JW; Jha S; Toedt-Pingel I; Ji SY; Nunez D; Ramachandran A; Anaya-Cisneros M; Tian R; Lefer DJ
Circ Res; 2009 Feb; 104(3):403-11. PubMed ID: 19096023
[TBL] [Abstract][Full Text] [Related]
10. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
[TBL] [Abstract][Full Text] [Related]
11. Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats.
Li J; Minćzuk K; Massey JC; Howell NL; Roy RJ; Paul S; Patrie JT; Kramer CM; Epstein FH; Carey RM; Taegtmeyer H; Keller SR; Kundu BK
J Am Heart Assoc; 2020 Apr; 9(7):e015154. PubMed ID: 32248762
[TBL] [Abstract][Full Text] [Related]
12. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
Louhelainen M; Vahtola E; Forsten H; Merasto S; Kytö V; Finckenberg P; Leskinen H; Kaheinen P; Tikkanen I; Levijoki J; Mervaala E
J Hypertens; 2009 Oct; 27(10):2094-107. PubMed ID: 19730126
[TBL] [Abstract][Full Text] [Related]
13. Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure.
Yurista SR; Matsuura TR; Silljé HHW; Nijholt KT; McDaid KS; Shewale SV; Leone TC; Newman JC; Verdin E; van Veldhuisen DJ; de Boer RA; Kelly DP; Westenbrink BD
Circ Heart Fail; 2021 Jan; 14(1):e007684. PubMed ID: 33356362
[TBL] [Abstract][Full Text] [Related]
14. Metformin improves cardiac function in mice with heart failure after myocardial infarction by regulating mitochondrial energy metabolism.
Sun D; Yang F
Biochem Biophys Res Commun; 2017 Apr; 486(2):329-335. PubMed ID: 28302481
[TBL] [Abstract][Full Text] [Related]
15. Digitoxin Attenuates Heart Failure, Reduces Myocardial Hypertrophy, and Preserves the Calcium-Binding Proteins in Infarcted Rats.
Picollo CT; Santos AAD; Antonio EL; Silva JMA; Bocalini D; Serra AJ; Ihara SSM; Tucci PJF
J Cardiovasc Pharmacol Ther; 2020 May; 25(3):265-272. PubMed ID: 31714152
[TBL] [Abstract][Full Text] [Related]
16. Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction.
Yurista SR; Silljé HHW; Oberdorf-Maass SU; Schouten EM; Pavez Giani MG; Hillebrands JL; van Goor H; van Veldhuisen DJ; de Boer RA; Westenbrink BD
Eur J Heart Fail; 2019 Jul; 21(7):862-873. PubMed ID: 31033127
[TBL] [Abstract][Full Text] [Related]
17. Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction.
Connelly KA; Zhang Y; Desjardins JF; Nghiem L; Visram A; Batchu SN; Yerra VG; Kabir G; Thai K; Advani A; Gilbert RE
Cardiovasc Diabetol; 2020 Feb; 19(1):13. PubMed ID: 32035482
[TBL] [Abstract][Full Text] [Related]
18. Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats.
Soraya H; Khorrami A; Garjani A; Maleki-Dizaji N; Garjani A
Pharmacol Rep; 2012; 64(6):1476-84. PubMed ID: 23406758
[TBL] [Abstract][Full Text] [Related]
19. Effects of the vasopeptidase inhibitor omapatrilat on peri- and postmyocardial infarction in Zucker lean rats.
Lapointe N; Parker TG; Tsoporis JN; Nguyen QT; Marcotte F; Adam A; Lou I; Rouleau JL
Can J Cardiol; 2005 Mar; 21(3):291-7. PubMed ID: 15776120
[TBL] [Abstract][Full Text] [Related]
20. Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991.
Zeng WT; Chen WY; Leng XY; Tang LL; Sun XT; Li CL; Dai G
Cardiovasc Ther; 2012 Jun; 30(3):152-61. PubMed ID: 21167013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
